January 27 2009 - The international architecture firm RMJM today announced the formation of a Global Health Studio (GHS). The GHS will be based in New York and will operate in Europe, North America, the Middle East and Asia. RMJM’s science and health experience includes designing state-of-the-art hospitals, cancer centers, medical schools and research centers for pharmaceutical and biotechnology companies. The new GHS follows the success of RMJM’s Global Education Studio, established in 2007. The GHS will be headed by Steven K. Gifford, Principal, with senior leaders in RMJM offices worldwide.
RMJM’s CEO Peter Morrison said, “RMJM’s combination of science, research and healthcare design experience is phenomenally powerful and the Global Health Studio will allow us to bring together our worldwide expertise in cutting-edge technologies to provide the best possible service for our clients. Healthcare is a strong market sector for us and in the current economy we will strengthen our business by investing in science and medicine.”
“Healthcare will be the world’s number one growth business,” said Steven Gifford, leader of the Global Health Studio. ”RMJM has a wealth of health and science experience across North America, Europe, Asia and the Middle East. RMJM’s team is committed to exploring and delivering creative design solutions in response to the growing convergence of healthcare delivery and translational medical research. This new studio structure will bring together our best designers and planners from across the world to create state-of-the-art healthcare and science facilities.”
RMJM has been a leader in designing facilities to serve the growing trend of international collaborations between leading western institutions and their partners elsewhere in the world. For example, RMJM is designing a Graduate Medical School for Duke University and the National University of Singapore.
Â
Existing RMJM health and research projects include hospitals in New York City, Philadelphia, Singapore and Princeton; medical schools for Duke, Robert Wood Johnson, LSU and Tulane; cancer centers in Alabama, New Orleans and Portugal, biotechnology facilities for Genzyme in China and Alexandria Properties in New York and pharmaceutical clients including GlaxoSmithKline, Bristol-Myers Squibb, Pfizer and Novartis.
RMJM is a UK-based international firm of architects with offices throughout the UK, Asia, the Middle East and the USA. Founded in 1956 by renowned British architects Robert Matthew and Stirrat Johnson-Marshall, today RMJM is one of the world’s largest architectural practices and employs approximately 1,200 people in 14 international offices in Cambridge, Dubai, Edinburgh, Glasgow, Hong Kong, London, Moscow, New York, Philadelphia, Princeton, Shanghai, Singapore, St Petersburg and Washington D.C. RMJM’s expertise and design-led approach is successfully demonstrated in on-going projects in more than 20 countries spanning a wide range of key sectors, from corporate headquarters and waterfront residential developments to major public buildings, university campuses and large-scale regeneration programmes. The company currently has over $15 billion worth of construction projects on its drawing boards, including some of the world’s most high profile and ambitious projects.
NEILL McG. COLEMAN
Communications Manager, U.S.
RMJM
275 Seventh Avenue, New York, NY 10001-6708 | T 212 629-4100 | F 212 629-4487 | rmjm.com
Press releases and images are available at www.rmjmpress.com
